0001104659-22-070661.txt : 20220613
0001104659-22-070661.hdr.sgml : 20220613
20220613201209
ACCESSION NUMBER: 0001104659-22-070661
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220610
FILED AS OF DATE: 20220613
DATE AS OF CHANGE: 20220613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dukes Iain D.
CENTRAL INDEX KEY: 0001681955
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40869
FILM NUMBER: 221013169
MAIL ADDRESS:
STREET 1: 112 W. 34TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theseus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001745020
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830712806
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 314 MAIN STREET, SUITE 04-200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (857) 400-9491
MAIL ADDRESS:
STREET 1: 314 MAIN STREET, SUITE 04-200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
tm2218348-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-06-10
0
0001745020
Theseus Pharmaceuticals, Inc.
THRX
0001681955
Dukes Iain D.
C/O THESEUS PHARMACEUTICALS, INC.
314 MAIN STREET, SUITE 04-200
CAMBRIDGE
MA
02142
1
1
0
0
Chairman
Stock Option (right to buy)
5.75
2022-06-10
4
A
0
30000
0
A
2032-06-09
Common Stock
30000
30000
D
Stock Option (right to buy)
5.75
2022-06-10
4
A
0
15000
0
A
2032-06-09
Common Stock
15000
15000
D
The options are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) June 10, 2023 or (ii) the day prior to the date of the issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service with the issuer on such vesting date.
The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with respect to 1/48th of the shares vesting monthly after June 10, 2022, subject to the Reporting Person's continuous service with the issuer on each such vesting date.
/s/ Bradford Dahms - Attorney-in-Fact
2022-06-13